CEO & CO-FOUNDER
PhD in Chemoinformatics
HEC Challenge + Program for Management of innovative companies
CSO & CO-FOUNDER
PhD in Computational Chemistry
HEC Challenge + program Management of innovative companies
Partnership Manager China
PhD in Computer Aided Drug Design,
Founder of the consultancy firm to help France and China collaboration, help penetrate the Chinese market and manage partnerships and relationships with stakeholders
Director of the SABNP INSERM Unit U1204 from University of Évry Paris-Saclay, inventor of the Microtubule Bench cell imaging technology licensed by SYNSIGHT.
President of the University of Évry Paris-Saclay, MD, Research director INSERM. Co-inventor of the MT bench cell imaging technology licensed by SYNSIGHT. He is President of the University of Evry Paris-Saclay.
Professor at the Institute of Biology of the École Normale Supérieure Paris (IBENS) of since 2013. Auguste leads the team of the CNRS UMR 8197 INSERM laboratory and is interested in the development of methods for the analysis of large data set (images for example).
Founding President of DC2A Consulting, Expert in Medicinal Chemistry. Denis provides drug discovery and medicinal chemistry consulting services to pharmaceutical and biotechnology companies.
Mr Junwei DUAN, Sponsor representative, has led dozens of IPOs and mergers and acquisitions, and has rich experience in capital markets. He is currently the vice president of Fenshare Holding (in charge of investment), and the chairman of Chongqing Modern Industrial Development Research Institute.
Mr Ling YUE, Sponsor representative, Chartered Financial Analyst, Director of Investment and Financing of Fenshare Holding, Director of Chartered Financial Analyst Association, Director of Tsinghua University Entrepreneurship and Investment Association.
JOIN THE TEAM !
GET IN TOUCH
We will get back to you as soon as possible